Cambridge Innovation Capital
Building technology and healthcare companies in the Cambridge Cluster.
|Address:||The Hauser Forum, 3 Charles Babbage Road, Cambridge|
|Membership type:||Corporate 6-20 (£250+VAT pa)|
CIC combines a unique relationship with the University of Cambridge with deep financial and industry links to support rapidly growing intellectual property rich companies in the Cambridge Cluster. The company is committed to building leading businesses from brilliant technologies, with the benefit of some of the most influential figures in the sector and a patient capital structure.
Cambridge Innovation Capital has led a £3.1 million seed funding round into AudioTelligence Limited, a company delivering real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.
11 September 2018Read in full
Cambridge Innovation Capital plc (CIC) has led a $14 million Series B funding round in Undo, a pioneer in the development of new software debugging technologies. The funding will be used to grow Undo’s software development team, accelerate its product development and expand its US operations.
16 July 2018Read in full
Cambridge Innovation Capital plc (CIC), which supports a portfolio of emerging technology and healthcare companies, has announced highlights from its annual results for the year ended 31 March 2018.
4 July 2018Read in full
Cambridge Innovation Capital (CIC) has participated in an £18.6 million funding round in Origami Energy. Aggreko plc, the FTSE-listed global leader in on-site power generation with a presence in over 100 countries, has made a major investment in this funding round. Other current investors also participated.
5 April 2018Read in full
The big challenge for developers of autonomous vehicles is ensuring that they operate effectively in the real world. To tackle this and similar challenges, Cambridge start-up PROWLER.io has raised £10 million in a series A funding round led by Cambridge Innovation Capital (CIC).
5 September 2017Read in full
Cambridge Innovation Capital (CIC) announces highlights from its annual results for the year ended 31 March 2017.
6 July 2017Read in full
The top blockbuster drug for 2016 was based on the techniques developed by Professor Sir Gregory Winter. Now his latest Cambridge company, Bicycle Therapeutics, has gained £40 million from investors including Cambridge Innovation Capital.
1 June 2017Read in full
Cambridge Innovation Capital (CIC), a Cambridge-based investor in technology and healthcare companies, announces that its CEO, Victor Christou, will be presenting at the Global University Venturing: Fusion event in London this evening (Weds).
24 May 2017Read in full